AMPHETAMINE-LIKE EFFECT OF L-DEPRENYL (SELEGILINE) IN DRUG DISCRIMINATION STUDIES

被引:22
作者
YASAR, S
BERGMAN, J
机构
[1] HARVARD UNIV,NEW ENGLAND REG PRIMATE RES CTR,SCH MED,SOUTHBOROUGH,MA 01772
[2] JOHNS HOPKINS UNIV,SCH MED,DEPT ANESTHESIOL & CRIT CARE MED,BALTIMORE,MD
[3] NIDA,PRECLIN PHARMACOL BRANCH,INTRAMURAL RES PROGRAM,BALTIMORE,MD
关键词
D O I
10.1038/clpt.1994.207
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
l-Deprenyl has dose-dependent amphetamine- and methamphetamine-like discriminative stimulus properties in rats and monkeys. However, these actions occur only at doses that are well above the clinically relevant dose range for l-deprenyl and are likely to reflect its metabolic conversion to amphetamine products. In view of its weak potency for producing amphetamine-like effects and their slow onset, it may not be surprising that l-deprenyl does not appear to have amphetamine-like abuse potential and has been used therapeutically in the treatment of Parkinson syndrome for more than 20 years with no reported instances of abuse.
引用
收藏
页码:768 / 773
页数:6
相关论文
共 31 条
[1]  
BIRKMAYER W, 1977, LANCET, V2, P439
[2]   CHRONIC PHENYLETHYLAMINE STEREOTYPY IN RATS - NEW ANIMAL-MODEL FOR SCHIZOPHRENIA [J].
BORISON, RL ;
HAVDALA, HS ;
DIAMOND, BI .
LIFE SCIENCES, 1977, 21 (01) :117-122
[3]   EFFECTS OF DIFFERENT MONOAMINE-OXIDASE INHIBITORS ON THE METABOLISM OF L-DOPA IN THE RAT-BRAIN [J].
BUU, NT ;
ANGERS, M .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (10) :1731-1735
[4]   EVIDENCE THAT A PREFERRED SUBSTRATE FOR TYPE-B MONOAMINE-OXIDASE MEDIATES STIMULUS PROPERTIES OF MAO INHIBITORS - A POSSIBLE ROLE FOR BETA-PHENYLETHYLAMINE IN THE COCAINE CUE [J].
COLPAERT, FC ;
NIEMEGEERS, CJE ;
JANSSEN, PAJ .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1980, 13 (04) :513-517
[5]  
COLPAERT FC, 1978, NEUROPHARMACOLOGY, V7, P937
[6]   COMPARISON OF DISCRIMINATIVE STIMULUS PROPERTIES OF COCAINE AND AMPHETAMINE IN RATS [J].
DMELLO, GD ;
STOLERMAN, IP .
BRITISH JOURNAL OF PHARMACOLOGY, 1977, 61 (03) :415-422
[7]   A PHARMACOLOGICAL ANALYSIS OF THE HYPERACTIVITY SYNDROME INDUCED BY BETA-PHENYLETHYLAMINE IN THE MOUSE [J].
DOURISH, CT .
BRITISH JOURNAL OF PHARMACOLOGY, 1982, 77 (01) :129-139
[8]  
ENGBERG G, 1991, J PHARMACOL EXP THER, V259, P841
[9]   EFFECT OF BETA-PHENYLETHYLAMINE ON CENTRAL AND PERIPHERAL MONOAMINE-CONTAINING NEURONS [J].
FUXE, K ;
GROBECKER, H ;
JONSSON, J .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1967, 2 (03) :202-+
[10]   POTENTIATION BY DEPRENYL OF 1-DOPA INDUCED CIRCLING IN NIGRAL-LESIONED RATS [J].
HEIKKILA, RE ;
CABBAT, FS ;
MANZINO, L ;
DUVOISIN, RC .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1981, 15 (01) :75-79